Anti-Asthma TDM Assay Kits Market Trends

  • Report ID: 4143
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Anti-Asthma TDM Assay Kits Market Trends

Growth Drivers

  • Increasing Consumption of Tobacco – Smoke affects the airways, which results in the same symptoms that occur during an asthma attack: swelling, narrowing, and the buildup of sticky mucus. Moreover, even if a person does not smoke, asthma can occur owing to secondhand smoke or passive smoking. Moreover, the pollutants from tobacco in the air can lead to acute sinusitis, which requires acute sinusitis treatment at an earlier stage, and it is anticipated to boost the market’s growth. According to the World Health Organization, around 1.2 million of those fatalities are caused by non-smokers being exposed to secondhand smoke, while more than 7 million are caused by direct tobacco use. Moreover, each year, more than 8 million people are killed by tobacco.
  • Rising Cases of Asthma – Growing cases of asthma are expected to boost the demand for anti-asthma TDM assay kits. In the US, 25 million people suffer from asthma. This equates to about 1 in every 13 people. Over 20 million Americans age 18 and over suffer from asthma.
  • Increasing Concentration of Pollutants in the Air– As per the data of the Environmental Protection Agency, between the years 1990-2020, the level of concentration of carbon monoxide and nitrogen increased by 73% and 61%, respectively. Moreover, the emission of sulfur dioxide increased by 91%, and the concentration of ozone and coarse particulate matter leveled up by 25% and 26%, respectively.
  • Growing Demand for Medical Precaution for Asthma – Diagnostic test can help the patient to know the severity of the issue and asthma & COPD drugs can help to even prevent it. Over the previous four years, sales of anti-asthma medications have increased by over 50% throughout the nation.
  • Rising Investment in Medicines for Asthma– The British pharmaceutical, AstraZeneca is investing about USD 77 million to increase respiratory drug production at its Sydney facility. This facility is expected to fulfill the rising demand in China for anti-asthmatic drugs.

Challenges

  • Shortage of skilled workers who can perform the test efficiently- The increasing cases of asthma in the world is growing the demand for anti-asthma TDM assay kits. These tests are best performed by the skilled worker, to acquire a result with precision. Therefore, a dearth of skilled workers is expected to hamper the market growth.
  • Lack of medical reimbursement policies for asthma patient
  • Lack of Awareness about anti-asthma test kits

Anti-Asthma TDM Assay Kits Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.8%

Base Year Market Size (2023)

USD 19.04 Billion

Forecast Year Market Size (2036)

USD 39.63 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4143
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of anti-asthma TDM assay kits is assessed at USD 20.03 Billion.

The anti-asthma TDM assay kits market size was over USD 19.04 Billion in 2023 and is likely to reach USD 39.63 Billion by the end of 2036, growing at around 5.8% CAGR during the forecast period i.e., between 2024-2036. The rising cases of asthma, rising air pollution, and growing demand for anti-asthma drugs are expected to be the major factor driving the growth of the global anti-asthma TDM assay kits market during the forecast period.

North America is expected to account for majority industry share by 2036, attributed to increasing count of patients suffering from asthma.

F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Svar Life Science AB, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, Elabscience Biotechnology Inc., MyBioSource Inc., Creative Diagnostics, Diagnostic Automation (Cortez Diagnostics, Inc.)
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample